Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-03-11 @ 11:06 PM
Study NCT ID:
NCT02982720
Status:
TERMINATED
Last Update Posted:
2022-02-16
First Post:
2016-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
Sponsor:
Aiwu Ruth He, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-01
First Submit QC Date:
None
Study First Post Date:
2016-12-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-16
Results First Submit QC Date:
None
Results First Post Date:
2019-06-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-14
Last Update Post Date:
2022-02-16
Last Update Post Date Type:
ACTUAL